Papers to Appear in Forthcoming Issues

(Received and Accepted Dates Follow Title) ide Based on the Sequence of the CDR3 of a Murine Anti-DNA mAb Is a Better Modulator of Experimental SLE Than Its Single Amino Acid-Substituted Analogs. Naama Brosh, Heidy Zinger, Mati Fridkin, and Edna Mozes. (Received 5/17/00; accepted 9/11/00.) ell Factor and IL-2 Act Synergistically in Inducing Intraepithelial Lymphocyte Proliferation and Cytokine Production: Upregulation of the IL-2 Receptor γ-Chain and Signaling via JAK-3. Tian Wang, Raeful Alam, Keith E. Langley, and Gary R. Klimpel. (Received 6/1/00; accepted 8/30/00.) Suppression in Adult Mice Injected with Anti-δ Followed by Anti-μ mAb. Aziz Alami Chentoufi, Yannick Nizet, Xavier Havaux, Françoise Nisol, Hervé Bazin, and Dominique Latinne. (Received 7/7/00; accepted 8/29/00.) ne Up-Regulates Expression of Substance P and Its Receptor in Human Blood Mononuclear Phagocytes and Lymphocytes. Yuan Li, Sha Tian, Steven D. Douglas, and Wen-Zhe Ho. (Received 7/7/00; accepted 9/15/00.) ent Roles for p55 and p75 Tumor Necrosis Factor Receptors in the Pathogenesis of MOG35-55-Induced Experimental Autoimmune Encephalomyelitis. Graig C. Suvannavejh, Hae-Ock Lee, Josette Padilla, Mauro C. Dal Canto, Terrance A. Barrett, and Stephen D. Miller. (Received 6/12/00; accepted 8/29/00.)